23 July 2019

Highlights from the Scientific Meeting on Tumor Heterogeneity

The aim was to exchange latest insights, approaches and model systems to understand the origins of heterogeneity and its implications for tumor evolution and therapy resistance.

Maria Hayat Content Manager

Throughout the year, Oncode Institute organizes various workshops and trainings to enhance knowledge and collaboration.

On June 24-25 Oncode, together with theme 2 & 3 leaders organized a 2-day event around the topic of Tumour Heterogeneity in which researchers from different disciplines were brought together for an informal meeting. The aim was to exchange latest insights, approaches and model systems to understand the origins of heterogeneity and its implications for tumor evolution and therapy resistance.

The meeting garnered great response from Oncode researchers, with almost 100 people in attendance. Young researchers and new Oncode Investigators were given a chance to talk about their science and discuss with the audience.

Winners of the team assignment

One of the highlights was the keynote lecture by Roel Nusse(Howard Hughes Medical Institute, Stanford School of Medicine), with the topic: Stemness: Permission to divide? In which he gave an excellent overview of the scientific developments throughout his career. The two days also featured engaging discussions on sub-topics like genotypic heterogeneity, phenotypic heterogeneity, novel targets for therapy and smart screens, the role of the microenvironment and novel technologies.

The format of the meeting was catered to maximize interaction and collaboration, so researchers were assigned to mixed groups with varied competences and backgrounds. On the first day, participants discussed in small groups their expertise and projects and got to know each other. The next day the goal was to work together on a joint research project, company or clinical study and develop a pitch for it. The meeting ended with the group pitches and an award ceremony for the best pitch.

The meeting was very interactive with an open atmosphere, lively discussions after each presentation and most participants staying over and enjoying the dinner and drinks afterwards.

Next workshop

We look forward to the next meeting scheduled for the first quarter in 2020, and welcome ideas for topics to be discussed. Please contact Ester Frische if you have any suggestions.

Other News

Oncode Icons Square 22
First Oncode Clinical Proof of Concept (CPoC) project now finalized
We are happy to announce that our first Oncode CPoC study - a collaboration between Oncode Investigator Jean Paul Medema (Amsterdam UMC) and clinician Henk Verheul (Radboud UMC) titled Pulsatile high dose Sunitinib as a specific drug for (a subset of) metastatic mesenchymal CRCs - is now finalized.
Bianca-OliviaNita
Oncode Icons Square research strategy copy
New CPoC grant awarded: researchers and clinicians team up for study on gastroenteropancreatic neuroendocrine tumors (GEPNETs)
Oncode Institute keeps investing in bringing insights from basic science into clinical practice. With the 12th grant awarded within the CPoC programme, Oncode Investigator Roland Kanaar together with Oncode researcher Julie Nonnekens (both Erasmus MC) will team up with a group of clinicians, a physicist and pharmacist for a project focused on gastroenteropancreatic neuroendocrine tumors (GEPNETs).
Bianca-OliviaNita
Oncode about icon copy 4
Oncode Facilities & Technologies will add value to your research
The goal of Oncode Institute is to translate the results of ground-breaking fundamental research into the clinic faster, in order to improve the chances of cancer patients. Investing in new technologies and facilities - which are available to all Oncode researchers - is one of the ways that Oncode wants to contribute to breakthroughs in cancer research. In this interview Jacqueline Staring, Programme Manager at Oncode Institute, discusses the facilities and technologies that are available for the Oncode research community and how they will support and accelerate oncology research.
ElizeBrolsma

<span>Elize</span><span>Brolsma</span>

Elize is part of Oncode’s communication team. She has over 10 years of experience in the com-munication industry, both for commercial and non-profit organisations. After obtaining her bache-lor and master degree in communication at Utrecht University, Elize worked as a communication professional at a research institute, PR agency, law firm and internet company. She has a strong focus on external communications and Public Relations. At Oncode - together with her colleagues - Elize produces the monthly newsletters for Oncode Investigators & Researchers and the Oncode digital magazine. She publishes content for the Oncode website and is responsible for all social media channels. She enjoys discussing science with researchers and support them in their outreach.